SCHEMBL13737142

SCHEMBL13737142

COC[C@H]1CC[C@H](Nc2ncc(C(N)=O)cn2)CC1

nearest known ligand 0.44

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
HDAC3 O15379 2/20 0.44
HDAC1 Q13547 2/20 0.44
HDAC2 Q92769 2/20 0.44
HDAC6 Q9UBN7 2/20 0.44
PARP15 Q460N3 1/20 0.43
PARP10 Q53GL7 1/20 0.43
PARP2 Q9UGN5 1/20 0.43
MAPK8 P45983 15/20 0.43
MAPK9 P45984 8/20 0.43
SYK P43405 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13737141 1.00 HDAC3 (0.44) HDAC3HDAC1HDAC2HDAC6PARP15
SCHEMBL14667236 0.84 HDAC1 (0.57) HDAC3HDAC1HDAC2HDAC6MAPK8
SCHEMBL13735187 0.82 MAPK8 (0.60) HDAC3HDAC1HDAC2HDAC6MAPK8
SCHEMBL13735184 0.82 MAPK8 (0.60) HDAC3HDAC1HDAC2HDAC6MAPK8
SCHEMBL21161949 0.79 MAPK8 (0.69) MAPK8MAPK9SYK
SCHEMBL29761508 0.79 MAPK8 (0.55) HDAC3HDAC1HDAC2HDAC6MAPK8
SCHEMBL17088451 0.78 MAPK8 (0.66) MAPK8MAPK9
SCHEMBL14658317 0.78 MAPK8 (0.66) MAPK8MAPK9
SCHEMBL17088493 0.78 MAPK8 (0.66) MAPK8MAPK9
SCHEMBL14658313 0.78 MAPK8 (0.66) MAPK8MAPK9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2699553-A1 SUBSTITUTED DIAMINOCARBOXAMIDE AND DIAMINOCARBONITRILE PYRIMIDINES, COMPOSITIONS THEREOF, AND METHODS OF TREATMENT THEREWITH Signal Pharmaceuticals, LLC (US) 2014-02-26 EP disclosed
WO-2012145569-A1 SUBSTITUTED DIAMINOCARBOXAMIDE AND DIAMINOCARBONITRILE PYRIMIDINES, COMPOSITIONS THEREOF, AND METHODS OF TREATMENT THEREWITH SIGNAL PHARMACEUTICALS, LLC (US) 2012-10-26 WO disclosed